Injectable Drug Delivery Devices Market Size, Share, Analysis, Trends, Growth, 2032

Injectable Drug Delivery Devices Industry Prospective:

The global injectable drug delivery devices market size was evaluated at $468 billion in 2023 and is slated to hit $577 billion by the end of 2032 with a CAGR of nearly 6.7% between 2024 and 2032.

Request Free Sample

Injectable Drug Delivery Devices Market: Overview

Injectable drug delivery devices are key tools in modern medicine, enabling proficient administration of pharmaceuticals. They encompass a slew of systems designed to improve patient compliance, enhance therapeutic outcomes, and enable self-administration. There are various kinds of injectable drug delivery devices such as needle-free injectors, conventional injection devices, pen injectors, auto-injectors, and wearable injectors.

Key Insights

• As per the analysis shared by our research analyst, the global injectable drug delivery devices market is projected to expand annually at the annual growth rate of around 6.7% over the forecast timespan (2024-2032)
• In terms of revenue, the global injectable drug delivery devices market size was evaluated at nearly $468 billion in 2023 and is expected to reach $577 billion by 2032.
• The global injectable drug delivery devices market is anticipated to grow rapidly over the forecast timeline owing to an increase in the occurrence of chronic ailments and technological breakthroughs such as the production of smart injectors, wearable equipment, and needle-free injectors.
• In terms of device type, the autoinjectors segment is slated to dominate the segmental space over forecast period.
• Based on product type, the drug-device combination products segment is predicted to lead the global industry surge in the ensuing years.
• Based on therapeutic area, the oncology segment is predicted to lead the segmental surge over the forecast period.
• Based on the end-user, the hospitals & clinics segment is predicted to contribute notably towards the industry size in the ensuing years.
• Region-wise, the Asia-Pacific injectable drug delivery devices industry is projected to register the fastest CAGR during the assessment timespan.

Injectable Drug Delivery Devices Market: Growth Factors

Humungous incidences of chronic disorders to boost the global market surge by 2032

An increase in the occurrence of chronic ailments and technological breakthroughs, such as the production of smart injectors, wearable equipment, and needle-free injectors, will steer the expansion of the global injectable drug delivery devices market. Apart from this, escalating demand for self-injectable equipment to empower patients to administrate medications at home will drive the global market trends.

Reportedly, enhanced healthcare spending, along with acceptance of injectable drug delivery services, are likely to foster the growth of the global market. Supportive government schemes and rapid acceptance of biosimilars and biologics are likely to impel the market surge globally.

Injectable Drug Delivery Devices Market: Restraints

Surging product prices to restrict the global industry expansion over the analysis period

High costs of manufacturing devices and complex supply chain activities are a few major restraints impacting the growth of the global injectable drug delivery devices industry. Strict laws needed to approve the new injectable equipment can halt the expansion of the global industry.

Injectable Drug Delivery Devices Market: Opportunities

Huge need for injections for geriatric population prone to chronic ailments to prop up the market expansion globally

Enhanced demand for injectable treatments for the aging population and a surge in patient-centric solutions are expected to open new growth avenues for the global injectable drug delivery devices market. Investments in strengthening the healthcare infrastructure facilities and flourishing e-commerce sector are likely to drive the growth of the global market.

Injectable Drug Delivery Devices Market: Challenges

Surging concerns about patient safety to challenge the global industry expansion by 2032

Growing safety issues, along with reduced shelf life & stability problems, can challenge the expansion of the global injectable drug delivery devices industry. Moreover, data security concerns and less awareness about the product benefits are projected to obstruct the global industry surge in the years ahead.

Injectable Drug Delivery Devices Market: Report Scope

Injectable Drug Delivery Devices Market: Segmentation

The global injectable drug delivery devices market is divided into device type, product type, therapeutic area, end-user, and region.                                                    

In terms of device type, the injectable drug delivery devices market across the globe is segmented into conventional injection devices, pen injectors, autoinjectors, wearable injectors, and needle-free injection devices segments. The autoinjectors segment is likely to be the leading segment among the device type segments during the forecast timeline. The rapid growth of this segment can be owing to the enhanced safety & convenience of the product and the growing frequency of chronic ailments.

Furthermore, beneficial features of the product, such as audible feedback, safety mechanisms, and dose counters, can reduce the risk of accidental injections along with improving the user-friendliness of the device.

On the basis of product type, the global injectable drug delivery devices industry is bifurcated into stand-alone devices and drug-device combination products segments. Furthermore, the drug-device combination products segment is likely to dominate the growth of the global industry in the coming few years. The key driving factors of the segmental growth can be enhanced therapeutic results, focus on targeted delivery, and technological breakthroughs.

Based on the therapeutic area, the global injectable drug delivery devices market is segregated into diabetes, hormone replacement therapy, oncology, autoimmune disorders, vaccines, and pain management segments. The oncology segment, which accounted majorly towards the global market share in 2023, is set to lead the segmental surge in the ensuing years. The growth can be attributed to breakthroughs in cancer therapies and surging cancer cases. Moreover, rising medical treatment charges are likely to prop up the segmental surge.

On the basis of end-user, the global injectable drug delivery devices industry is bifurcated into pharmacies, hospitals & clinics, home care settings, ambulatory care centers, and research & development institutes segments. Moreover, the hospitals & clinics segment is expected to proliferate the size of the global market in the coming years subject to a high volume of injections, complex medical treatments, and the availability of experts in hospitals & clinics.

Injectable Drug Delivery Devices Market: Regional Insights

North America is projected to maintain a leading position in the global market over the expected timeline

North America, which contributed approximately 54% of the global injectable drug delivery devices market earnings in 2023, is expected to maintain a dominant status in the coming few years.

Apparently, the growth of the market in North America over the forecast timeline can be due to the strong presence of key medical device manufacturers in the U.S. Additionally, the use of new biotechnologies and immense healthcare spending is projected to boost the regional industry surge.

The Asia-Pacific injectable drug delivery devices industry is set to record the highest CAGR in the forecast period. The industry expansion in the region can be credited to the rapidly growing economies of emerging nations of Asia and the rising aging populace prone to geriatric diseases. Presence of strong healthcare infrastructure facilities in the countries such as South Korea, China, Japan, and India will steer the industry space in Asia-Pacific.

Injectable Drug Delivery Devices Market: Competitive Space

The global injectable drug delivery devices market profiles key players such as:

• Schott AG
• Gerresheimer AG
• Becton
• Dickinson and Company
• Amgen Inc.
• Ypsomed AG
• Sanofi
• Eli Lilly and Company
• Pfizer Inc.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Terumo Corporation
• West Pharmaceutical Services Inc.
• Novo Nordisk
• Medtronic plc
• AstraZeneca
• Enable Injections

The global injectable drug delivery devices market is segmented as follows:

By Device Type

• Conventional Injection Devices
• Pen Injectors
• Autoinjectors
• Wearable Injectors
• Needle-Free Injection Devices

By Product Type

• Stand-Alone Devices
• Drug-Device Combination Products

By Therapeutic Area

• Diabetes
• Hormone Replacement Therapy
• Oncology
• Autoimmune Disorders
• Vaccines
• Pain Management

By End-User

• Pharmacies
• Hospitals & Clinics
• Home Care Settings
• Ambulatory Care Centers
• Research & Development Institutes

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa